Multiple Sclerosis Clinical Trials

Showing 1261-1280 of 2,839 trials

Efficacy of MYCOBIOTIC® in Children and Adults With Abdominal Symptoms.

NCT04909437

This is a prospective, randomised, double blind, placebo controlled, parallel arm, cross-over, multicentre study conducted in a population of children and adults with abdominal symptoms observed at outpatient primary health care centres.

Abdominal SymptomsStool Culture Positive for Candida Species

Nature Science Sp. z o.o.105 participantsStarted May 2021

Kielce, Poland • Kielce, Poland • Kielce, Poland +3 more locations

COMPLETEDNA

Assessment of Deep Gray Matter Anatomic Changes in RRMS Patients Treated With Gilenya® With and Without Cognitive Impairment Over a 2 Year Period Using NeuroQuant, NeuroQuarc and ANAM

NCT05684016

The purpose of the research study is to investigate whether the extent and severity of lesions in the brain as measured by special MRI techniques can distinguish between Multiple Sclerosis (MS) patients with or without memory impairment and also between MS patients and age matched healthy controls.

Multiple Sclerosis, Relapsing-Remitting

George Washington University75 participantsStarted Dec 2013

Washington D.C., District of Columbia, United States

COMPLETEDPhase 3

An Investigation of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis Patients

NCT01610700

A study to compare the efficacy of GW-1000-02 \[named Sativex® in Canada and also named Sativex® Oromucosal Spray\] with placebo in relieving five key symptoms of Multiple Sclerosis after six weeks of therapy.

Multiple Sclerosis

Jazz Pharmaceuticals160 participantsStarted May 2001

Oxford, United Kingdom

Efficacy of MYCOBIOTIC® in Children and Adults With Abdominal Symptoms.

Assessment of Deep Gray Matter Anatomic Changes in RRMS Patients Treated With Gilenya® With and Without Cognitive Impairment Over a 2 Year Period Using NeuroQuant, NeuroQuarc and ANAM

An Investigation of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis Patients

Related Searches

a Study of Combined mpMRI and PSMA PET/CT for Highly Suspicious Patients Performing Radical Prostatectomy Without Biopsy

A Study of Lenvima (Lenvatinib) in Korean Unresectable Hepatocellular Carcinoma (uHCC) Participants

Strategies for Coping With Negative Thoughts

COVID-19 and SARS-CoV-2 Antibodies in Multiple Sclerosis Patients

The Safety Management of Cardiac Toxicity in Breast Cancer Patients Under Multidiscipline Therapy.

Exercise Prescription Dose for Castration Resistance Prostate Cancer Patients

The Effect of Education Given at Different Times Before a Breast Biopsy

Utomilumab and ISA101b Vaccination in Patients With HPV-16-Positive Incurable Oropharyngeal Cancer

Neoadjuvant Envafolimab in Resectable and Locally Advanced MSI-H/dMMR Rectal Cancer

Teriflunomide Concentration in Serum and Cerebrospinal Fluid From Patients With Multiple Sclerosis

A Study on the Efficacy of Agomelatine Combined With Antipsychotics to Treat Negative Symptoms in Schizophrenia

Ideal Drainage Output of Post-operative Neck Suction Drain

Sleep and Quality of Life Among Postmenopausal Women

Phase 2 Study of Standard Chemotherapy With Trastuzumab, Plus or Minus Pertuzumab, for Pre-treated Metastatic Breast Cancer

Effect of Human Papillomavirus Self-Collection on Cervical Cancer Screening in High Risk Women: My Body, My Test 3

[68Ga]Ga-ABY-025 PET for Quantification of HER2-status in Solid Tumors

Transcranial Direct Current Stimulation to Lower Neuropathic Pain in People With Multiple Sclerosis